| Literature DB >> 30833333 |
Rudy Jacquet1, Annette E LaBauve2, Lavoisier Akoolo3, Shivani Patel1, Abdulelah A Alqarzaee4, Tania Wong Fok Lung1, Kunal Poorey5, Timothy P Stinear6, Vinai C Thomas4, Robert J Meagher2, Dane Parker7,3.
Abstract
Staphylococcus aureus is a major human pathogen of the skin. The global burden of diabetes is high, with S. aureus being a major complication of diabetic wound infections. We investigated how the diabetic environment influences S. aureus skin infection and observed an increased susceptibility to infection in mouse models of both type I and type II diabetes. A dual gene expression approach was taken to investigate transcriptional alterations in both the host and bacterium after infection. While analysis of the host response revealed only minor changes between infected control and diabetic mice, we observed that S. aureus isolated from diabetic mice had significant increases in the levels of genes associated with translation and posttranslational modification and chaperones and reductions in the levels of genes associated with amino acid transport and metabolism. One family of genes upregulated in S. aureus isolated from diabetic lesions encoded the Clp proteases, associated with the misfolded protein response. The Clp proteases were found to be partially glucose regulated as well as influencing the hemolytic activity of S. aureus Strains lacking the Clp proteases ClpX, ClpC, and ClpP were significantly attenuated in our animal model of skin infection, with significant reductions observed in dermonecrosis and bacterial burden. In particular, mutations in clpP and clpX were significantly attenuated and remained attenuated in both normal and diabetic mice. Our data suggest that the diabetic environment also causes changes to occur in invading pathogens, and one of these virulence determinants is the Clp protease system.Entities:
Keywords: Clp protease; Staphylococcus aureuszzm321990; diabetes; host-pathogen interactions
Mesh:
Year: 2019 PMID: 30833333 PMCID: PMC6479027 DOI: 10.1128/IAI.00163-19
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441